In addition to targeting tumor angiogenesis, PPARγ ligands have direct effects on cancer cells due to their ability to promote apoptosis, inhibit cell proliferation or induce differentiation [3, 71, 185–188]. This evidence concerns the gene PPARG and neoplasm.